The proportional change in maximum height for the five study groups. by Teagan McMahon (20108036)

Changes in inflammatory cell count in BALF of mice exposed to continuous CS inhalation. by Yue He (385239)

Subjects:

Changes in the expression of inflammatory cytokines in BALF of mice exposed to continuous CS inhalation. by Yue He (385239)

Subjects:

Ozone ultrafine bubble water decreases gingipain activities in <i>Porphyromonas gingivalis</i> culture supernatant. by Mana Endo (22430706)

Bar charts showing the numbers of significantly differentially expressed genes for the different contrasts. by Gillian P. McHugo (8965919)

“…<p>The extent of the bar above and below 0 on the vertical axis indicates the numbers of significantly differentially expressed genes (DEGs; B-H <i><i>P</i></i><sub>adj.…”

Change in temperature from baseline. by Katharyn L. Flickinger (4759323)

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

RTA408 significantly reduces RGCs loss in glaucoma. by Hongmei Qian (538647)

Time series comparing trends at HSJ and control hospitals in the pre-intervention and intervention period. Significance test determine if trends differ between groups. by Eva Rydahl (6260771)

Subjects:

Changes in the neutrophil count. by Lu Yang (30847)

“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”

Changes in the platelet count. by Lu Yang (30847)

“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”

Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

Subjects:

Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

Subjects:

Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

Subjects:

Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

Subjects:

Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

Subjects:

Land use change from 1990 to 2020. by Mingyue Sun (4638535)

Changes in the number of cultural heritages over time. by Jie Li (15030)